Search

everythinglearnresearchcommunity

for

Search:↓

Personalized treatment with inhibitors, minoxidil, and laser therapy helps hair loss.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

Finasteride can treat hair loss, but may have side effects; evaluate and inform patients of risks.

People with first-time vitiligo have lower levels of a certain brain protein compared to healthy individuals.

Finasteride can cause sexual dysfunction and depression, which may persist and require hormonal treatment.

Finasteride worsens stress effects on sensory processes, possibly linking to anxiety/depression.

AGA is a common hair loss disorder, and early diagnosis and treatment with minoxidil or finasteride can help reduce emotional distress.

Personality traits significantly affect the onset, progression, and psychological impact of alopecia areata.

Nanotechnology shows promise in improving hair loss treatments by enhancing drug delivery and reducing side effects.

Minoxidil and spironolactone can improve hair growth, but responses vary and side effects are common.

Continuous use of finasteride and minoxidil is effective for treating androgenetic alopecia.

Post-finasteride syndrome can cause sexual and systemic side effects, and patients should be informed about these risks.

Quality of life improved after COVID-19, but ongoing health support is needed.

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

Genetic variations greatly affect individual metabolism and can impact health and disease risk.

KAP genes show significant genetic variability, but its impact on hair traits is unclear.

Americans see hair transplants as valuable for treating hair loss and want them to be more affordable and tailored to each gender.

In the Jazan region of Saudi Arabia, hair loss is common, especially among women, older people, and those with higher education and BMI. Stress, poor nutrition, and hormonal changes are key causes, but many don't seek medical help.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

New therapies for alopecia areata show potential but need more research.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

Bald men should protect their scalps from the sun to reduce skin cancer risk.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

UK dermatologists commonly use corticosteroids and minoxidil to treat hair loss conditions.

Patients with cutaneous lupus erythematosus have a severely impaired quality of life, especially emotionally.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

The guideline provides recommendations for managing alopecia areata effectively.

People with alopecia areata are more likely to have major depression, possibly linked to a specific genetic region.